Journal articleClin Gastroenterol Hepatol · July 2026
Morbidity and mortality from cirrhosis is increasing, and it is mainly driven by liver-associated decompensation. Liver transplantation (LT) is the only curative treatment for decompensated cirrhosis and selected liver-related complications and malignancie ...
Full textLink to itemCite
Journal articleAm J Transplant · June 2026
Allocation out-of-sequence (AOOS) refers to deviation from the match run order in deceased donor organ allocation and is intended for use in exceptional cases to expedite organ placement. Contemporary patterns of AOOS in liver transplantation are not well ...
Full textLink to itemCite
Journal articleAm J Transplant · March 26, 2026
Cytomegalovirus (CMV) causes significant morbidity in CMV donor seropositive/recipient seronegative (D+R-) solid organ transplant recipients, but organ-specific differences in CMV epidemiology and the utility of laboratory surveillance after prophylaxis (S ...
Full textLink to itemCite
Journal articleInfect Control Hosp Epidemiol · December 2025
OBJECTIVE: Diagnostic stewardship of blood culture utilization is important to mitigate the risks associated with unnecessary culturing. Although blood culture algorithms have been studied previously, there is a lack of data on their application among soli ...
Full textOpen AccessLink to itemCite
Journal articleAm J Transplant · August 2025
With the expansion of solid organ transplantation activities in the United States, there is a critical need for more transplant care providers and trainees to sustain and advance the field of transplantation. However, there has been a pending shortage of t ...
Full textLink to itemCite
Journal articleLiver Transpl · June 1, 2025
Normothermic machine perfusion (NMP) facilitates the utilization of marginal liver allografts. It remains unknown whether clinical benefits offset additional costs in the real-world setting. We performed a comparison of outcomes and hospitalization costs f ...
Full textLink to itemCite
Journal articleClin Transplant · June 2025
BACKGROUND: Transplantation of hepatitis C virus (HCV) nucleic acid (NAT) positive organs is associated with shorter time to transplant and decreased risk of death on the waiting list. Treatment for HCV post-transplant is well-tolerated, successful, and le ...
Full textLink to itemCite
Journal articleCA Cancer J Clin · 2025
Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third leading cause of cancer-related death worldwide. Contemporary advances in systemic and locoregional therapies have led to changes in peer-reviewed guidelines regarding systemi ...
Full textLink to itemCite
Journal articleTransplant Direct · December 2024
BACKGROUND: Invasive primary surgical site infections (IP-SSI) are a severe complication of liver transplant surgery. Identification of risk factors for IP-SSI is critical to IP-SSI prevention. METHODS: All adult single liver transplants performed at Duke ...
Full textOpen AccessLink to itemCite
Journal articleLiver Transpl · September 1, 2024
Health care transition (HCT) is a vulnerable period that continues into adulthood, even after the transfer of care. Given the growing population of pediatric liver transplant recipients reaching young adulthood, the need for a standardized and multidiscipl ...
Full textLink to itemCite
Journal articleHepatol Commun · August 1, 2024
Health care transition (HCT) is the process of changing from a pediatric to an adult model of care. Young adult pediatric recipients of liver transplant transferring from pediatric to adult health care services are highly vulnerable and subject to poor lon ...
Full textLink to itemCite
Journal articlePediatr Transplant · August 2024
BACKGROUND: An increasing number of pediatric solid organ transplant (SOT) recipients are surviving into adolescence and young adulthood. The transition from pediatric to adult-oriented care occurs during a unique and vulnerable period. METHODS: Presented ...
Full textLink to itemCite
Journal articleAntimicrob Agents Chemother · March 6, 2024
Invasive primary Candida surgical site infections (IP-SSIs) are a common complication of liver transplantation, and targeted antifungal prophylaxis is an efficient strategy to limit their occurrence. We performed a retrospective single-center cohort study ...
Full textLink to itemCite
Journal articleClin Liver Dis · February 2024
Autoimmune liver diseases have unique post-transplant considerations. These recipients are at increased risk of rejection, and recurrent disease may also develop, which can progress to graft loss and increase mortality. Monitoring for and managing these co ...
Full textLink to itemCite
Journal articleTransplant Direct · November 2023
BACKGROUND: Hepatitis C virus (HCV) nucleic acid amplification test (NAAT)-positive donors have increased the organ pool. Direct-acting antivirals (DAAs) have led to high rates of treatment success and sustained virologic response (SVR) in recipients with ...
Full textLink to itemCite
ConferenceClin Transplant · August 2023
Despite the increased risk of non-adherence, allograft rejection, and mortality following transfer from pediatric to adult care in liver transplantation (LT), there is no standardized approach to health care transition (HCT). Two electronic national survey ...
Full textLink to itemCite
Journal articleDig Dis Sci · March 2023
BACKGROUND AND AIMS: Patients with primary biliary cholangitis (PBC) often suffer with pruritus. We describe the impact of pruritus on quality of life and how it is managed in a real-world cohort. METHODS: TARGET-PBC is a longitudinal observational cohort ...
Full textLink to itemCite
Journal articleJ Pediatr Gastroenterol Nutr · January 1, 2023
Advances in medical therapies and liver transplantation have resulted in a greater number of pediatric patients reaching young adulthood. However, there is an increased risk for medical complications and morbidity surrounding transfer from pediatric to adu ...
Full textLink to itemCite
Journal articleTransplant Direct · January 2021
BACKGROUND: Midodrine is often needed pretransplant to improve hemodynamics in simultaneous liver-kidney transplant candidates. Previous research has shown that patients requiring midodrine before kidney transplant alone have increased posttransplant risk ...
Full textLink to itemCite
Journal articleRadiology · July 2019
Background In 2017, the Liver Imaging Reporting and Data System (LI-RADS) included an algorithm for the assessment of hepatocellular carcinoma (HCC) treated with local-regional therapy. The aim of the algorithm was to enable standardized evaluation of trea ...
Full textLink to itemCite
ConferenceCancer Research · July 1, 2018
AbstractWorldwide, hepatocellular carcinoma (HCC) is the fifth most common cancer and the second-leading cause of cancer-related death worldwide. In the U.S., the incidence rate of HCC has tripled since 1975 ...
Full textCite
Journal articleHepatology · May 2018
UNLABELLED: Type 2 diabetes (T2D) is a risk factor for hepatocellular carcinoma (HCC). However, it is unknown whether T2D duration or additional metabolic comorbidities further contribute to HCC risk. From the Nurses' Health Study (NHS), 120,826 women were ...
Full textLink to itemCite
Journal articleDig Dis Sci · November 2017
BACKGROUND: There is increasing evidence for a heterogeneity of phenotypes in primary sclerosing cholangitis (PSC), but differences across the age spectrum in adults with PSC have not been well characterized. AIMS: To characterize phenotypic variations and ...
Full textLink to itemCite
Journal articleLiver Transpl · June 2017
Liver retransplantation in patients with primary sclerosing cholangitis (PSC) has not been well studied. The aims of this study were to characterize patients with PSC listed for and undergoing retransplantation and to describe the outcomes in these patient ...
Full textLink to itemCite
Journal articleClinical and Translational Gastroenterology · March 1, 2017
OBJECTIVES: Hepatocellular carcinoma (HCC) surveillance with biannual ultrasound is currently recommended for all patients with cirrhosis. However, clinical implementation of this “one-size-fits-all” approach is challenging as evidenced by its low applicat ...
Full textCite
Journal articleAm J Med · June 2016
BACKGROUND: Gastrointestinal bleeding is a well-known risk of systemic anticoagulation. However, bleeding in the setting of supratherapeutic anticoagulation may have a milder natural history than unprovoked bleeding. It is a common clinical gestalt that en ...
Full textLink to itemCite
Journal articleClin Transplant · April 2016
Hepatitis C virus (HCV) infection is accelerated following liver transplantation (LT). Single nucleotide polymorphisms (SNPs) near the epidermal growth factor (EGF) (rs4444903), IL28B (rs12979860), and PNPLA3 (rs738409) loci are associated with treatment r ...
Full textLink to itemCite
Journal articleCancer Prev Res (Phila) · December 2015
Chronic inflammation plays a pivotal role in the pathogenesis of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), the two most common types of liver cancer. A number of prior experimental studies have suggested that nonsteroidal an ...
Full textLink to itemCite
Journal articleClinical and Translational Gastroenterology · October 8, 2015
OBJECTIVES: Soluble CD163 (sCD163), a marker of Kupffer cell activation detectable in serum, correlates with inflammation and fibrosis in chronic viral hepatitis, but its role in nonalcoholic fatty liver disease is unknown. We hypothesized that sCD163 woul ...
Full textCite
Journal articleCancer Epidemiol Biomarkers Prev · September 2015
BACKGROUND: Coffee consumption has been reported to be inversely associated with hepatocellular carcinoma (HCC), the most common type of liver cancer. Caffeine has chemopreventive properties, but whether caffeine is responsible for the coffee-HCC associati ...
Full textLink to itemCite
Journal articleGut · August 2015
OBJECTIVE: The number of patients with HCV-related cirrhosis is increasing, leading to a rising risk of complications and death. Prognostic stratification in patients with early-stage cirrhosis is still challenging. We aimed to develop and validate a clini ...
Full textLink to itemCite
Journal articleDig Dis Sci · August 2015
BACKGROUND AND AIMS: Nonalcoholic fatty liver disease (NAFLD) and obstructive sleep apnea (OSA) are growing in prevalence in the USA. Existing data on the relationship between OSA and NAFLD are conflicting and limited by the use of various histologic defin ...
Full textLink to itemCite
Journal articleDig Dis Sci · July 2015
BACKGROUND: LVP is used to manage diuretic-resistant ascites in cirrhotic patients. Albumin administration prevents complications including acute kidney injury and paracentesis-induced circulatory dysfunction, but the optimal dose is unclear. AIM: We sough ...
Full textLink to itemCite
Journal articleBr J Cancer · March 31, 2015
BACKGROUND: Hepatocellular carcinoma (HCC) occurs less commonly among women than men in almost all regions of the world. The disparity in risk is particularly notable prior to menopause suggesting that hormonal exposures during reproductive life may be pro ...
Full textLink to itemCite
Journal articleDig Dis Sci · February 2015
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD), the most common cause of liver disease, is frequently diagnosed incidentally on imaging. The goal of the present study was to characterize rates of documentation and evaluation of incidentally identifie ...
Full textLink to itemCite
Journal articleJ Hepatol · January 2015
BACKGROUND & AIMS: Therapies that slow fibrosis progression in chronic liver disease are needed. Animal models have demonstrated that statins prevent the progression of hepatic fibrosis, but human data is lacking so far. We evaluated the association betwee ...
Full textLink to itemCite
Journal articleAnnu Rev Pathol · 2015
Hepatitis C virus (HCV) is one of the major etiologic agents of liver cancer. HCV is an RNA virus that, unlike hepatitis B virus, is unable to integrate into the host genome. Through complex interactions between viral and host proteins that induce host res ...
Full textLink to itemCite
Journal articlePLoS One · 2014
Single nucleotide polymorphisms (SNPs) in the epidermal growth factor (EGF, rs4444903), patatin-like phospholipase domain-containing protein 3 (PNPLA3, rs738409) genes, and near the interleukin-28B (IL28B, rs12979860) gene are linked to treatment response, ...
Full textLink to itemCite
Journal articleDigestive Diseases and Sciences · January 1, 2014
Background and Aims: Hospital admissions in cirrhotic patients are a source of significant health care expenditure. Most studies to date have focused on readmissions in patients with decompensated cirrhosis. We sought to describe predictors of hospital adm ...
Full textCite
Journal articleGastroenterology · November 2012
BACKGROUND & AIMS: Patients with acute liver failure (ALF) have high mortality and frequently require liver transplantation (LT); few reliable prognostic markers are available. Levels of M30, a cleavage product of cytokeratin-18 caspase, are significantly ...
Full textLink to itemCite
Journal articleOncologist · 2010
Four cases highlighting the reactivation of hepatitis B virus during chemotherapy are presented and the current data and guidelines for pre-emptive management are reviewed. ...
Full textLink to itemCite